Your browser doesn't support javascript.
loading
IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status.
Nandre, Rahul; Verma, Vivek; Gaur, Pankaj; Patil, Veerupaxagouda; Yang, Xingdong; Ramlaoui, Zainab; Shobaki, Nour; Andersen, Mads Hald; Pedersen, Ayako Wakatsuki; Zocca, Mai-Britt; Mkrtichyan, Mikayel; Gupta, Seema; Khleif, Samir N.
Afiliación
  • Nandre R; The Center for Immunology and Immunotherapy, The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Verma V; Georgia Cancer Center, Augusta University, Augusta, Georgia.
  • Gaur P; The Center for Immunology and Immunotherapy, The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Patil V; Georgia Cancer Center, Augusta University, Augusta, Georgia.
  • Yang X; The Center for Immunology and Immunotherapy, The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Ramlaoui Z; Georgia Cancer Center, Augusta University, Augusta, Georgia.
  • Shobaki N; The Center for Immunology and Immunotherapy, The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Andersen MH; Georgia Cancer Center, Augusta University, Augusta, Georgia.
  • Pedersen AW; The Center for Immunology and Immunotherapy, The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Zocca MB; The Center for Immunology and Immunotherapy, The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Mkrtichyan M; The Center for Immunology and Immunotherapy, The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Gupta S; IO Biotech ApS, København, Denmark.
  • Khleif SN; IO Biotech ApS, København, Denmark.
Cancer Immunol Res ; 10(5): 571-580, 2022 05 03.
Article en En | MEDLINE | ID: mdl-35290437
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cancer Immunol Res Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cancer Immunol Res Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos